CLINICAL_TRIALS trial_result · 2019-11-29

Clinical Trial Update: Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) [Phase 2]

Phase 2 clinical trial results update for AC220 in treating Acute Myeloid Leukemia has been completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Daiichi Sankyo | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-11-29